Dido Franceschi

Author PubWeight™ 43.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol 2006 2.08
2 Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg 2006 1.90
3 Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res 2007 1.82
4 Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003 1.62
5 Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol 2008 1.60
6 African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 2008 1.57
7 Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012 1.57
8 Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol 2007 1.55
9 Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg 2007 1.55
10 The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc 2011 1.52
11 Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007 1.48
12 Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus? Ann Surg Oncol 2009 1.44
13 Breast cancer in limited-resource countries: early detection and access to care. Breast J 2006 1.43
14 Surgical management of primary breast sarcoma. Am Surg 2002 1.24
15 Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg 2011 1.19
16 Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol 2007 1.11
17 Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol 2007 1.10
18 The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol 2009 1.09
19 Male breast cancer: is the incidence increasing? Ann Surg Oncol 2004 1.08
20 Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 2006 1.04
21 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg 2007 0.97
22 Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer? J Surg Res 2012 0.88
23 Depth of injury caused by liquid nitrogen cryospray: study of human patients undergoing planned esophagectomy. Dig Dis Sci 2014 0.87
24 Gastric decompression and enteral feeding through a double-lumen gastrojejunostomy tube improves outcomes after pancreaticoduodenectomy. Ann Surg 2004 0.87
25 Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease. J Surg Oncol 2012 0.86
26 How many lymph nodes properly stage a periampullary malignancy? J Gastrointest Surg 2007 0.85
27 Are we training our residents to perform open gall bladder and common bile duct operations? J Surg Res 2007 0.84
28 Gender- and race-specific comparison of tobacco-associated cancer incidence trends in Florida with SEER regional cancer incidence data. Cancer Causes Control 2008 0.83
29 Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002 0.83
30 Tracheobronchial injury in the setting of an esophagectomy for cancer: postoperative discovery a bad omen. J Surg Oncol 2014 0.82
31 Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer. Jpn J Clin Oncol 2007 0.81
32 A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma. Jpn J Clin Oncol 2011 0.81
33 Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities? J Surg Oncol 2010 0.80
34 African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change? J Am Coll Surg 2009 0.80
35 Surgery for rectal cancer performed at teaching hospitals improves survival and preserves continence. J Gastrointest Surg 2007 0.79
36 Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination. J Gastrointest Surg 2007 0.78
37 Pancreaticoduodenectomy in the presence of superior mesenteric venous obstruction. J Gastrointest Surg 2005 0.78
38 Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomas. Ann Surg Oncol 2013 0.77
39 A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer. Anticancer Drugs 2007 0.75